HBM HOLDINGS-B(02142),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02142 HBM HOLDINGS-B

Market Closed 04-17 16:08:09

7.180

+0.000

0.00%

High7.460	Low7.120	Vol4.46M
Open7.200	D1 Closing7.180	Amplitude4.74%
Mkt Cap6.00B	Tradable Cap6.00B	Total Shares835.00M
T/O32.42M	T/O Rate0.53%	Tradable Shares835.00M
P/B6.21	ROE2.25%	EPS0.03
52wk High10.000	52wk Low1.010	P/E255.76
Dividend0.00	Div.Yield0.00	ROA-1.04%

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"02142","market":"HK","secType":"STK","nameCN":"HBM HOLDINGS-B","latestPrice":7.18,"timestamp":1744877289031,"preClose":7.18,"halted":0,"volume":4464000,"delay":0,"floatShares":835000000,"shares":835000000,"eps":0.028073008454509458,"marketStatus":"Market Closed","change":0,"latestTime":"04-17 16:08:09","open":7.2,"high":7.46,"low":7.12,"amount":32421734,"amplitude":0.047354,"askPrice":7.21,"askSize":1000,"bidPrice":7.18,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":0.027917737390048675,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745285400000},"marketStatusCode":7,"adr":0,"listingDate":1607529600000,"exchange":"SEHK","adjPreClose":7.18,"openAndCloseTimeList":[[1744853400000,1744862400000],[1744866000000,1744876800000]],"volumeRatio":0.5170855777967371,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02142","defaultTab":"news","newsList":[{"id":"2526803896","title":"HBM Plans Up to HK$200 Million Share Buyback; Shares Surge 12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526803896","media":"MT Newswires Live","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526803896?lang=en_us&edition=full_marsco","pubTime":"2025-04-11 15:50","pubTimestamp":1744357855,"startTime":"0","endTime":"0","summary":"HBM  plans to repurchase up to HK$200 million of shares under a buyback mandate, according to a Thursday filing with the Hong Kong bourse.The drug company has so far allocated HK$240 million for share buybacks in 2025 on a year-to-date basis, the filing said.Shares surged 12% during Friday's afternoon trading.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","BK1161","02142","BK1583"],"gpt_icon":0},{"id":"2526597191","title":"BRIEF-HBM Holdings Intends To Repurchase Shares Of Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2526597191","media":"Reuters","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526597191?lang=en_us&edition=full_marsco","pubTime":"2025-04-10 23:33","pubTimestamp":1744299194,"startTime":"0","endTime":"0","summary":"BRIEF-HBM Holdings Intends To Repurchase Shares Of CoApril 10 (Reuters) - Hbm Holdings Ltd 2142.HK:INTENDS TO REPURCHASE SHARES OF CO IN OPEN MARKET FROM TIME TO TIME UP TO HK$200 MILLIONFurther company coverage: 2142.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nFWN3QO1H6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1574","BK1161","02142"],"gpt_icon":0},{"id":"2526556200","title":"Hbm Holdings -  Intends to Repurchase Shares of Co in Open Market From Time to Time up to HK$200 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2526556200","media":"THOMSON REUTERS","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526556200?lang=en_us&edition=full_marsco","pubTime":"2025-04-10 21:29","pubTimestamp":1744291797,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nFWN3QO1H6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","BK1161","02142","BK1574"],"gpt_icon":0},{"id":"2526637338","title":"Harbour Biomed Appoints Youchen Chen as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2526637338","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526637338?lang=en_us&edition=full_marsco","pubTime":"2025-04-10 10:00","pubTimestamp":1744250405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nTUA6Z4B35:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1574","BK1583","02142"],"gpt_icon":0},{"id":"2524251465","title":"HBM Holdings' 2024 Profit Shrinks","url":"https://stock-news.laohu8.com/highlight/detail?id=2524251465","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524251465?lang=en_us&edition=full_marsco","pubTime":"2025-04-02 18:48","pubTimestamp":1743590934,"startTime":"0","endTime":"0","summary":"HBM's  profit plunged to $2.7 million in 2024 from $22.8 million in 2023.The drug company logged zero earnings per share during the year compared with $0.03 in the previous year, according to a Monday filing with the Hong Kong bourse.Revenue shrank to $38.1 million from $89.5 million a year earlier.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1583","BK1161","BK1574","02142"],"gpt_icon":0},{"id":"2524487348","title":"HBM Holdings Reports Full Year 2024 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2524487348","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524487348?lang=en_us&edition=full_marsco","pubTime":"2025-04-02 07:50","pubTimestamp":1743551416,"startTime":"0","endTime":"0","summary":"HBM Holdings ( HKG:2142 ) Full Year 2024 Results Key Financial Results Revenue: US$38.1m (down 57% from FY 2023). Net...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/hbm-holdings-reports-full-year-2024-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02142"],"gpt_icon":0},{"id":"2523879919","title":"Harbour Biomed Reports Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2523879919","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523879919?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 18:13","pubTimestamp":1743416021,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nTUA5CH63Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","02142","BK1161","BK1583"],"gpt_icon":0},{"id":"2523191987","title":"Press Release: Harbour BioMed Reports Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2523191987","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523191987?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 18:13","pubTimestamp":1743415980,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 31, 2025. CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 31, 2025 /PRNewswire/ -- Harbour BioMed , a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced its financial results for the year ended December 31, 2024.Dr. Jingsong Wang, Founder, Chairman, and CEO of Harbour BioMed,  commented: \"The year 2024 was a pivotal period for Harbour BioMed, marked by significant progress in research and development, strategic business expansion, and operational excellence. Despite a challenging macroeconomic environment, the Company demonstrated remarkable resilience, navigating inflationary pressures, global supply chain disruptions, and geopolitical uncertainties while remaining focused on its long-term growth objectives.Compared to 2023, the company's revenue sustainability has continued to improve. Annual recurring revenue in","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSLP","BK4585","BK4022","TM","03160","BK4213","02142","BK4588","BK4099","BK1574","BK4604","BK1583","BK4232","BK4555","SD","BK1161","R"],"gpt_icon":0},{"id":"2521730625","title":"Harbour BioMed Shares Soar on News of AstraZeneca Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2521730625","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521730625?lang=en_us&edition=full_marsco","pubTime":"2025-03-24 11:00","pubTimestamp":1742785200,"startTime":"0","endTime":"0","summary":"Shares of Harbour BioMed soared after the Chinese biopharmaceutical firm announced a collaboration with U.K. pharma giant AstraZeneca, which plans to invest $2.5 billion in China.The stock rose as much as 28% to 10.00 Hong Kong dollars, equivalent to US$1.29, in early Monday trade in Hong Kong, before paring gains to 7.15%.AstraZeneca's five-year US$2.5 billion investment, announced on Friday, includes a new research-and-development center in Beijing and a research agreement with Harbour BioMed. The U.K. firm will also acquire 9.15% in newly issued shares of the Hong Kong-listed pharma group.The collaboration is aimed at discovering and developing next-generation multi-specific antibodies, including for immunology and oncology, Harbour BioMed said separately on Friday.Under the agreement, Harbour BioMed stands to receive US$175 million in upfront payment, near-term milestone payments and option exercise fees for additional programs. It is also eligible for up to US$4.4 billion in addit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02142","BK1583","LU2456880835.USD","BK4007","LU0320765992.SGD","LU1829250122.USD","LU2236285917.USD","BK4585","BK1574","BK4568","LU0109394709.USD","LU2417539215.USD","LU2462157665.USD","BK4588","AZN","LU0889565916.HKD"],"gpt_icon":0},{"id":"1139940615","title":"Stock Track | HBM Holdings Soars 11.62% on Strategic Partnership with AstraZeneca","url":"https://stock-news.laohu8.com/highlight/detail?id=1139940615","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139940615?lang=en_us&edition=full_marsco","pubTime":"2025-03-24 09:48","pubTimestamp":1742780929,"startTime":"0","endTime":"0","summary":"HBM Holdings-B  saw its stock price soar by 11.62% in Monday's trading session following the announcement of a strategic collaboration with pharmaceutical giant AstraZeneca. The partnership includes a share subscription agreement and a joint venture to develop next-generation multi-specific antibodies, signaling a significant boost for HBM's market position and future prospects.The collaboration's centerpiece is AstraZeneca's agreement to subscribe to 9.15% of HBM's shares, injecting approximate","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | HBM Holdings Soars 11.62% on Strategic Partnership with AstraZeneca","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02142"],"gpt_icon":0},{"id":"2521239358","title":"BRIEF-HBM Holdings To Issue To Astrazeneca Holdings Subscription Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2521239358","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521239358?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 23:28","pubTimestamp":1742570903,"startTime":"0","endTime":"0","summary":"BRIEF-HBM Holdings To Issue To Astrazeneca Holdings Subscription SharesMarch 21  - Hbm Holdings Ltd 2142.HK:TO ISSUE TO ASTRAZENECA HOLDINGS SUBSCRIPTION SHARES AT US$1.38 PER SHAREGROSS PROCEEDS FROM SUBSCRIPTION WILL BE US$105.3 MILLIONFurther company coverage: 2142.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nFWN3Q31DW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0526926950.USD","02142","LU0310799852.SGD","LU1003077747.HKD","LU0976567544.SGD","LU1487256676.USD","LU2023251221.USD","LU1983299246.USD","LU1061106388.HKD","LU1267930227.SGD","LU1880407215.USD","LU0997586432.USD","LU0171293334.USD","LU0128525689.USD","LU2279689827.SGD","LU2089283258.USD","LU0211326839.USD","LU0203345920.USD","LU1019634622.SGD","IE00BJJMRZ35.SGD","LU0545039389.USD","IE00B2B36J28.USD","LU1267930573.SGD","LU0114720955.EUR","LU0949170772.SGD","LU0823399737.USD","LU1057294990.SGD","LU0969580561.USD","IE00B3T34201.USD","LU1023059063.AUD","LU1496350502.SGD","LU1015430645.USD","LU1481599808.USD","BK1161","03165","AZN.UK","LU0047473722.EUR","LU0158827948.USD","LU0640478417.SGD","LU2089284900.SGD","IE0002141913.USD","LU0029864427.USD","LU0553294199.USD","LU0784384876.USD","SG9999001176.SGD","LU2324357040.USD","LU0792757196.USD","SGXZ57979304.SGD","LU2108987350.USD","LU0882574055.USD"],"gpt_icon":0},{"id":"2521407683","title":"BRIEF-Harbour Biomed Enters Into Global Strategic Collaboration With Astrazeneca","url":"https://stock-news.laohu8.com/highlight/detail?id=2521407683","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521407683?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 19:26","pubTimestamp":1742556406,"startTime":"0","endTime":"0","summary":"BRIEF-Harbour Biomed Enters Into Global Strategic Collaboration With Astrazeneca March 21 (Reuters) - Hbm Holdings Ltd 2142.HK:HARBOUR BIOMED ENTERS INTO GLOBAL STRATEGIC COLLABORATION WITH ASTRAZENEC","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nTUA4GWFPF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0949170772.SGD","LU1015430645.USD","LU0963555726.SGD","LU2108987350.USD","AZN.UK","LU0211328371.USD","LU2468319806.SGD","LU0310800379.SGD","LU0047473722.EUR","LU0211326755.USD","LU0964806797.USD","LU0171293334.USD","IE0002141913.USD","LU0972486137.USD","LU0052756011.USD","LU1051770623.HKD","BK1161","LU1019634622.SGD","LU1153584641.USD","LU1003076772.USD","LU0553294199.USD","03165","LU1989772923.USD","LU1019632923.USD","LU1291159041.SGD","LU0211326839.USD","LU1880407215.USD","LU1989771016.USD","LU1481600234.SGD","LU2112291526.USD","LU0211327993.USD","LU0203347892.USD","LU2279689827.SGD","LU0575583348.USD","LU0122379950.USD","LU1064927863.SGD","LU0823399737.USD","IE00BJJMRZ35.SGD","LU0011850046.USD","BK5011","LU0957799991.USD","SG9999001176.SGD","02142","LU1267930813.SGD","SG9999001176.USD","IE00B4R5TH58.HKD","LU0792757196.USD","LU0345777147.USD","LU1003077747.HKD","LU0496365809.HKD"],"gpt_icon":0},{"id":"2521940781","title":"Hbm Holdings Ltd - Harbour Biomed to Receive $175 Million Upfront and up to $4.4 Billion in Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2521940781","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521940781?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 19:21","pubTimestamp":1742556085,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nTUA4GWFPF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02142","BK1583","BK1574","BK1161"],"gpt_icon":0},{"id":"2521640788","title":"Harbour Biomed Enters Into Global Strategic Collaboration With AstraZeneca to Discover and Develop Next-Generation Therapeutic Antibodies","url":"https://stock-news.laohu8.com/highlight/detail?id=2521640788","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521640788?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 19:21","pubTimestamp":1742556085,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nTUA4GWFPF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","BK1161","02142","BK1574"],"gpt_icon":0},{"id":"2521407815","title":"Hbm Holdings Ltd - AstraZeneca to Acquire 9.15% Newly Issued Shares of Harbour Biomed","url":"https://stock-news.laohu8.com/highlight/detail?id=2521407815","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521407815?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 19:21","pubTimestamp":1742556085,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nTUA4GWFPF:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","BK1161","02142","BK1574"],"gpt_icon":0},{"id":"2521742402","title":"Hbm Holdings -  to Issue to AstraZeneca Holdings Subscription Shares at US$1.38 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2521742402","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521742402?lang=en_us&edition=full_marsco","pubTime":"2025-03-21 19:20","pubTimestamp":1742556049,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nFWN3Q31DW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1583","BK1161","02142"],"gpt_icon":0},{"id":"2518378047","title":"Harbour Biomed Appoints DR. Ian Y. Liu as Global Head of Legal","url":"https://stock-news.laohu8.com/highlight/detail?id=2518378047","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518378047?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 08:00","pubTimestamp":1741651206,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nTUALF2FN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","BK1161","02142","BK1574"],"gpt_icon":0},{"id":"2518478780","title":"Harbour Biomed Appoints Michael D. Patten as Chief Strategy Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2518478780","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518478780?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 08:00","pubTimestamp":1741651206,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nTUABWMBS0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","02142","BK1161","BK1583"],"gpt_icon":0},{"id":"2518780477","title":"Press Release: Harbour BioMed Appoints Dr. Ian Y. Liu as Global Head of Legal","url":"https://stock-news.laohu8.com/highlight/detail?id=2518780477","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518780477?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 08:00","pubTimestamp":1741651200,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 10, 2025. CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 10, 2025 /PRNewswire/ -- Harbour BioMed , a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and oncology, today announced the appointment of Dr. Ian Y. Liu as Senior Vice President, Global Head of Legal. Dr. Liu will be based in the U.S. and report directly to Dr. Jingsong Wang, Founder, Chairman, and CEO of Harbour BioMed.With his extensive legal expertise and industry experience, Dr. Liu will oversee business development transactions, ensuring legal and regulatory compliance while facilitating seamless execution to safeguard the company's interests. He will also lead the company's global intellectual property strategy. Additionally, Dr. Liu will take full responsibility for managing U.S.-related legal affairs, including prosecution and litigation of all l","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","R","BK4232","BK1583","BK4022","BK1574","02142"],"gpt_icon":0},{"id":"2518780470","title":"Press Release: Harbour BioMed Appoints Michael D. Patten as Chief Strategy Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2518780470","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518780470?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 08:00","pubTimestamp":1741651200,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 10, 2025. CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 10, 2025 /PRNewswire/ -- Harbour BioMed , a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and oncology, today announced the appointment of Michael D. Patten as Chief Strategy Officer. Michael will be based in the United States and report directly to Dr. Jingsong Wang, Founder, Chairman, and CEO of Harbour BioMed.In this role, Michael will be responsible for formulating and overseeing the global corporate development and growth strategy for Harbour BioMed. In addition, as the Head of Global Alliance, he will lead efforts to manage and strengthen Harbour BioMed's global strategic partner network and ecosystem, with a particular focus on high-potential markets outside of China, further enhancing Harbour BioMed's global branding and presence.Michael holds a B","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK4022","R","BK1574","BK1161","BK4588","BK4595","BK4596","BK4600","BK4232","STRK","BK4023","BK4516","02142","BK4585"],"gpt_icon":1}],"profile":{"stockEarnings":[{"period":"1week","weight":0.1097},{"period":"1month","weight":-0.169},{"period":"3month","weight":1.4931},{"period":"6month","weight":4.6984},{"period":"1year","weight":5.5872},{"period":"ytd","weight":2.8602}],"compareEarnings":[{"period":"1week","weight":0.0345},{"period":"1month","weight":-0.1352},{"period":"3month","weight":0.0925},{"period":"6month","weight":0.0284},{"period":"1year","weight":0.3165},{"period":"ytd","weight":0.0666}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Hbm Holdings Ltd is an investment holding company mainly engaged in the business of developing therapeutics in the fields of immuno-oncology and immunology diseases. The Company's products include HBM9161, HBM4003, HBM7008 and HBM1020. Batoclimab (HBM9161) is mainly used for immune thrombocytopenia (ITP), graves’ ophthalmopathy (GO), myasthenia gravis (MG), neuromyelitis optica spectrum disorder (NMOSD). Tanfanercept (HBM9036) is mainly used for dry eye disease (DED). The Company also researches and develops immuno-oncology portfolio, including internally developed next generation immune-oncology assets targeting immune-desert, immune-excluded and inflamed tumors. The Company owns Harbour Mice Platform, generating fully human monoclonal antibodies in the classical two heavy and two light chain H2L2 format as well as heavy chain only (HCAb) format.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.104328},{"month":2,"riseRate":0.2,"avgChangeRate":-0.004171},{"month":3,"riseRate":0.4,"avgChangeRate":0.046232},{"month":4,"riseRate":0.4,"avgChangeRate":-0.018239},{"month":5,"riseRate":0.5,"avgChangeRate":0.040975},{"month":6,"riseRate":0.25,"avgChangeRate":-0.069984},{"month":7,"riseRate":0.25,"avgChangeRate":0.010824},{"month":8,"riseRate":0,"avgChangeRate":-0.134459},{"month":9,"riseRate":0.25,"avgChangeRate":-0.098643},{"month":10,"riseRate":0,"avgChangeRate":-0.190485},{"month":11,"riseRate":0.75,"avgChangeRate":0.322177},{"month":12,"riseRate":0.75,"avgChangeRate":0.358142}],"exchange":"SEHK","name":"HBM HOLDINGS-B","nameEN":"HBM HOLDINGS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"HBM HOLDINGS-B(02142),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest HBM HOLDINGS-B(02142) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"HBM HOLDINGS-B,02142,HBM HOLDINGS-B股票,HBM HOLDINGS-B股票老虎,HBM HOLDINGS-B股票老虎国际,HBM HOLDINGS-B行情,HBM HOLDINGS-B股票行情,HBM HOLDINGS-B股价,HBM HOLDINGS-B股市,HBM HOLDINGS-B股票价格,HBM HOLDINGS-B股票交易,HBM HOLDINGS-B股票购买,HBM HOLDINGS-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"HBM HOLDINGS-B(02142),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest HBM HOLDINGS-B(02142) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}